SGS - Life Science Services White Papers

A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit growth. There are a number of trends and forces within the pharmaceutical industry that are causing companies to rethink their approaches to growth and cost management. To find out more, please download this free white paper.
View white paper
Marketing Authorisation Procedures in the European Union – Making the Right Choice The European Union, consisting of 27 Member States, has continuously worked on improving and streamlining drug review and marketing authorisation processes. There are currently three different procedures that can be used to submit a medicinal product for marketing approval in the EU. This free white paper briefly outlines the available avenues and describes when one might be used over another.
View white paper
Why, When and How to Conduct 14C Human Studies Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, the conduct of a radiolabeled human ADME study is recognised to be necessary in order to fulfil the requirements of the last guidance on safety testing of drug metabolism. To find out more, please download this free white paper.
View white paper